
The ratio of apolipoprotein B/apolipoprotein A-I (i.e., atherogenic to
atheroprotective lipoproteins) was the strongest predictor of
cardiovascular risk, according to pooled analyses of two recent major
statin studies, presented at the American Heart Association Scientific
Sessions.